Similarly, 4-1BB-mediated costimulation at the tumor site can enhance T-cell activation mediated by a BsAb [22,23], as evidenced by increased T-cell cytokine release, activation marker expression, and proliferation. This evidence concerns the gene TNFRSF9 and neoplasm.